Tag Archives: MACK

Best Value Stocks For 2019

Dividend investors have no fewer than 41 high-quality undervalued blue-chip stocks to choose from.

Thats according to Investment Quality Trends, a dividend stock advisory service edited by Kelley Wright. According to my firms performance tracking, it is one of the best-performing investment newsletters over the long term, beating the broad U.S. stock market by a large margin. In addition, it is in first place for risk-adjusted performance over both the trailing 20- and 30-year periods among services I monitor.

Best Value Stocks For 2019: Empire State Realty Trust, Inc.(ESRT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Kempen Capital Management N.V. purchased a new stake in Empire State Realty Trust Inc (NYSE:ESRT) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 602,051 shares of the real estate investment trust’s stock, valued at approximately $10,108,000.

  • [By Shane Hupp]

    Empire State Realty Trust, Inc. (NYSE:ESRT), a leading real estate investment trust (REIT), owns, manages, operates, acquires and repositions office and retail properties in Manhattan and the greater New York metropolitan area, including the Empire State Building, the world's most famous building. Headquartered in New York, New York, the Company's office and retail portfolio covers 10.1 million rentable square feet, as of March 31, 2018, consisting of 9.4 million rentable square feet in 14 office properties, including nine in Manhattan, three in Fairfield County, Connecticut, and two in Westchester County, New York; and approximately 700,000 rentable square feet in the retail portfolio.

  • [By Logan Wallace]

    Prudential Financial Inc. cut its stake in Empire State Realty (NYSE:ESRT) by 0.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,745,889 shares of the real estate investment trust’s stock after selling 8,046 shares during the quarter. Prudential Financial Inc.’s holdings in Empire State Realty were worth $29,313,000 at the end of the most recent quarter.

  • [By ]

    Empire State Realty Trust (ESRT) : “The yield on this one is too low.”

    DowDuPont (DWDP) : “I’m not running away, I’m sticking with them.”

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Empire State Realty Trust (ESRT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    For example, nobody is going to come along and build another Empire State Building. In fact, you can actually invest in this building through the Empire State Realty Trust (NYSE: ESRT).

Best Value Stocks For 2019: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Edited Transcript of MACK earnings conference call or presentation 8-May-18 12:30pm GMT (finance.yahoo.com) Investors Purchase High Volume of Merrimack Pharmaceuticals Call Options (MACK) (americanbankingnews.com) Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1 (finance.yahoo.com) Merrimack Pharmaceuticals (MACK) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS (americanbankingnews.com) Merrimack Pharmaceuticals’ (MACK) CEO Richard Peters on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com)

    A number of equities analysts have issued reports on MACK shares. Robert W. Baird reiterated a “hold” rating and issued a $12.00 price objective on shares of Merrimack Pharmaceuticals in a report on Thursday, March 15th. Zacks Investment Research upgraded Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective for the company in a report on Wednesday, April 25th.

  • [By Max Byerly]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod (finance.yahoo.com) Merrimack Fails Phase 2 Pancreatic Cancer Study, But Opportunity Remains (seekingalpha.com) Merrimack Pharmaceuticals’ (MACK) “Hold” Rating Reaffirmed at Robert W. Baird (americanbankingnews.com) Merrimack Crashes as Phase II Pancreatic Cancer Study Fails (zacks.com) MM-141 (benzinga.com)

    Several equities analysts have commented on MACK shares. Zacks Investment Research raised Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a research report on Wednesday, April 25th. JPMorgan Chase & Co. downgraded Merrimack Pharmaceuticals from a “neutral” rating to an “underweight” rating in a research report on Monday. Robert W. Baird cut their price objective on Merrimack Pharmaceuticals from $12.00 to $7.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, ValuEngine raised Merrimack Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Tuesday.

  • [By Chris Lange]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) shares were absolutely crushed on Monday after the firm gave an update from its midstage pancreatic cancer study. Specifically, the top-line results come from the CARRIE study, a randomized Phase 2 trial evaluating the addition of MM-141 (istiratumab) to standard-of-care treatment in patients with previously untreated metastatic pancreatic cancer.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

Best Value Stocks For 2019: Sorrento Therapeutics, Inc.(SRNE)

Advisors’ Opinion:

  • [By ]

    In the Lightning Round, Cramer was bullish on Spotify (SPOT) , Alkermes (ALKS) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Sorrento Therapeutics (SRNE) , NVIDIA (NVDA) , Nucor, Eli Lilly (LLY) and Kohlberg Kravis Roberts (KKR) .

  • [By Keith Speights]

    Shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) are down 10.2% as of 3:12 p.m. EDT Thursday on higher-than-average volume, but it’s not clear what’s going on with the biotech. Sorrento announced on Tuesday morning that it was acquiring Kimberly Clark’s Sofusalymphatic delivery technology, which consists ofnano-structured microneedles to deliver drugs into lymphatic capillaries beneath the skin.

  • [By ]

    Sorrento Therapeutics (SRNE) : “This is the kind of speculative stock that I like.”

    Geron (GERN) : “Let’s stick with high quality like Thermo Fisher Scientific (TMO) .”

  • [By Ethan Ryder]

    Sorrento Therapeutics Inc (NASDAQ:SRNE) shares gapped down before the market opened on Monday . The stock had previously closed at $6.75, but opened at $6.55. Sorrento Therapeutics shares last traded at $6.35, with a volume of 2670350 shares traded.

  • [By Steve Symington]

    But some individual stocks missed out on the positive mood prevailing on Wall Street. Read on to learn why Clean Energy Fuels (NASDAQ:CLNE), Sorrento Therapeutics (NASDAQ:SRNE), and iQiyi (NASDAQ:IQ)slumped today.

  • [By William Romov]

    San Diego-based Sorrento Therapeutics Inc. (Nasdaq: SRNE) develops drugs to treat certain types of cancer and chronic cancer pain.

    On Jan. 6, company officials will present a new proprietary technology for the treatment of cancer. Analysts are calling this new technology a potential “game-changer.”

Best Value Stocks For 2019: Edwards Lifesciences Corporation(EW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Westpac Banking Corp raised its stake in Edwards Lifesciences (NYSE:EW) by 22.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 67,689 shares of the medical research company’s stock after purchasing an additional 12,500 shares during the period. Westpac Banking Corp’s holdings in Edwards Lifesciences were worth $9,444,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Edwards Lifesciences (NYSE:EW) VP Jean-Luc M. Lemercier sold 5,634 shares of the company’s stock in a transaction on Wednesday, May 9th. The stock was sold at an average price of $134.91, for a total transaction of $760,082.94. Following the sale, the vice president now directly owns 38,784 shares of the company’s stock, valued at $5,232,349.44. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Edwards Lifesciences Corp (NYSE: EW) reported better-than-expected results for its first quarter, but issued weak earnings guidance for the second quarter. Edwards Lifesciences shares tumbled 7.80 percent to $124.17 in the after-hour

  • [By ]

    Edwards Lifesciences (EW) : “They have the best devices. That stock is a buy.”

    Align Technology (ALGN) : “The stock is breaking down. Let’s wait a few days then pull the trigger.”

  • [By Shane Hupp]

    Here are some of the media headlines that may have effected Accern Sentiment’s rankings:

    Get Edwards Lifesciences alerts:

    Edwards Lifesciences (EW) Receives New Coverage from Analysts at Raymond James (americanbankingnews.com) [$$] ValueAct/Olympus: zoom out (finance.yahoo.com) Analysts Expect Edwards Lifesciences (EW) to Post $1.12 EPS (americanbankingnews.com) Global Central Venous Catheters Market Emerging Technology by 2023: Edwards Lifesciences, Teleflex, Lepu Medical … (thebiotechnologynews.com) Global Pulmonary Artery Catheter Market Size 2018 Edwards Lifesciences Corporation, Argon Medical, BD and … (thecleantechnology.com)

    A number of research firms have weighed in on EW. JMP Securities upped their price target on Edwards Lifesciences from $135.00 to $140.00 and gave the stock a “market outperform” rating in a report on Friday, February 2nd. SunTrust Banks restated a “buy” rating and issued a $150.00 price target on shares of Edwards Lifesciences in a report on Wednesday, January 31st. Guggenheim restated a “buy” rating and issued a $162.00 price target on shares of Edwards Lifesciences in a report on Friday, February 2nd. ValuEngine upgraded Edwards Lifesciences from a “hold” rating to a “buy” rating in a report on Monday, May 7th. Finally, Barclays upped their price target on Edwards Lifesciences from $135.00 to $155.00 and gave the stock an “overweight” rating in a report on Friday, February 2nd. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Edwards Lifesciences currently has an average rating of “Buy” and an average target price of $149.06.

Best Value Stocks For 2019: ENSERVCO Corporation(ENSV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Enservco (NYSEAMERICAN:ENSV) will be issuing its quarterly earnings data before the market opens on Wednesday, May 9th.

    Enservco (NYSEAMERICAN:ENSV) last issued its earnings results on Thursday, March 22nd. The oil and gas producer reported ($0.04) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.03). Enservco had a negative return on equity of 89.94% and a negative net margin of 43.71%. The business had revenue of $14.13 million during the quarter.

Top 10 Value Stocks To Invest In Right Now

After a rally in the first half of 2016, Coach’s (NYSE:COH) stock price has witnessed a decline, to levels seen at the beginning of the year. The company’s closing price rose to a high of $43.46 on August 1, but has seen a steady decline thereafter, with fears of a poor year-end performance. While Coach isn’t alone in being out of favor in the retail industry, however, given its recent performance, the decline in its share price may not be warranted. According to Trefis’ estimates, Coach’s stock price has an intrinsic value of $44.02, implying a 24% upside potential. Below, we have highlighted some factors which we feel justify this price point.

Click to enlarge

Top 10 Value Stocks To Invest In Right Now: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

  • [By Shane Hupp]

    Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Edited Transcript of MACK earnings conference call or presentation 8-May-18 12:30pm GMT (finance.yahoo.com) Investors Purchase High Volume of Merrimack Pharmaceuticals Call Options (MACK) (americanbankingnews.com) Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1 (finance.yahoo.com) Merrimack Pharmaceuticals (MACK) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS (americanbankingnews.com) Merrimack Pharmaceuticals’ (MACK) CEO Richard Peters on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com)

    A number of equities analysts have issued reports on MACK shares. Robert W. Baird reiterated a “hold” rating and issued a $12.00 price objective on shares of Merrimack Pharmaceuticals in a report on Thursday, March 15th. Zacks Investment Research upgraded Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective for the company in a report on Wednesday, April 25th.

Top 10 Value Stocks To Invest In Right Now: Enpro Industries(NPO)

Advisors’ Opinion:

  • [By Max Byerly]

    News coverage about EnPro Industries (NYSE:NPO) has been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. EnPro Industries earned a daily sentiment score of 0.07 on Accern’s scale. Accern also gave news articles about the industrial products company an impact score of 46.9443513305379 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    New York State Common Retirement Fund grew its holdings in EnPro Industries, Inc. (NYSE:NPO) by 19.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,168 shares of the industrial products company’s stock after purchasing an additional 5,888 shares during the quarter. New York State Common Retirement Fund owned approximately 0.17% of EnPro Industries worth $2,799,000 at the end of the most recent quarter.

Top 10 Value Stocks To Invest In Right Now: Northrop Grumman Corporation(NOC)

Advisors’ Opinion:

  • [By Rich Smith]

    Orbital plans to begin ground-testing the rocket next year, by which time Orbital ATK will probably have been subsumed into new owner Northrop Grumman (NYSE:NOC). In anticipation of testing beginning, Orbital gave NGL an official name last month: OmegA.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Rich Smith]

    Nine months in the making, Northrop Grumman’s (NYSE:NOC) $9.2 billion acquisition of space company Orbital ATK is now a done deal.

    Earlier this month, Northrop confirmed that having just received antimonopoly clearance from the Federal Trade Commission, it had immediately proceeded to close its purchase of smaller aerospace company Orbital ATK. Northrop wasted no time in stamping its mark on its new prize, renaming it Northrop Grumman Innovation Systems (NGIS) and designating it Northrop’s “new, fourth business sector.”

  • [By Elizabeth Balboa]

    Northrop Grumman Corporation (NYSE: NOC) and Lockheed Martin Corporation (NYSE: LMT) traded up 3.8 percent and 1.4 percent, respectively.

    Boeing Co. (NYSE: BA) actually rose on the news despite now having to reconsider its recently negotiated a $20 billion sale to Iran.

  • [By Lou Whiteman]

    Lockheed Martin (NYSE:LMT) has selected Raytheon (NYSE:RTN) to replace Northrop Grumman (NYSE:NOC) as supplier of a key sensor system on its F-35 fighter aircraft, a move the lead contractor said will save the program more than $3 billion.

  • [By Chris Dier-Scalise]

    What gives? Well, all of the top six holdings in the fund—Boeing Co (NYSE: BA), United Technologies Corporation (NYSE: UTX), Lockheed Martin Corporation (NYSE: LMT), General Dynamics Corporation (NYSE: GD), Raytheon Company (NYSE: RTN), and Northrup Grumman Corporation (NYSE: NOC)—all either met or exceeded Q4 earnings estimates. Together, those six companies make up about 45 percent of the fund.

Top 10 Value Stocks To Invest In Right Now: Cogentix Medical, Inc.(CGNT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News coverage about Vision Sciences (NASDAQ:CGNT) has trended somewhat positive on Friday, Accern reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Vision Sciences earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave news headlines about the medical device company an impact score of 43.7920504117832 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Value Stocks To Invest In Right Now: Euro FX(P)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Pandora Media Inc (NYSE:P) saw a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 61,707,852 shares, a decline of 13.7% from the April 30th total of 71,509,016 shares. Based on an average trading volume of 13,506,224 shares, the short-interest ratio is presently 4.6 days. Approximately 25.0% of the shares of the stock are sold short.

  • [By Lisa Levin]

    Friday afternoon, the information technology shares rose 1.9 percent. Meanwhile, top gainers in the sector included Pandora Media, Inc. (NYSE: P), up 23 percent, and Super Micro Computer, Inc. (NASDAQ: SMCI) up 16 percent.

  • [By Rick Munarriz]

    The beat and the beats go on atPandora (NYSE:P). Shares of the streaming music icon soared 26% after posting blowout financial results. A pair of analysts would go on to upgrade the stock, and a third Wall Street pro joined them in jacking up price targets on the shares.

  • [By Garrett Baldwin]

    Yesterday, the Fed Open Market Committee announced it would not raise interest rates this session. The central bank committee, which is in charge of monetary policy, said that inflation is rising and that the U.S. economy is getting better. Markets are now looking forward to the next meeting on June 12 for the U.S. Federal Reserve to bump rates higher for the second time in 2018. Shares of Tesla Inc. (Nasdaq: TSLA) slumped more than 4.5% after Tesla CEO Elon Musk held an highly unusual earnings call. After announcing that his firm burned through $700 million in cash during the quarter of 2018, Musk refused to take any more questions on the company’s fiscal health, dismissing analysts’ questions as “boring.” Musk instead spent the rest of the quarterly call taking questions from a YouTuber named Gali Russell who had lobbied Musk on Twitter to let him partake in the earnings call. This morning, the U.S. Labor Department reported initial jobless claims rose by 2,000, to 211,000. Analysts had projected 225,000 for the week. The tightening U.S. labor market has now seen the total number of Americans receiving benefits fall to the lowest level since 1973. America’s unemployment rate is sitting at 4.1%, the lowest figure in 17 years. Tomorrow, the Labor Department will release the April jobs report.
    Four Stocks to Watch Today: GPRO, SPOT, CI
    GoPro Inc. (Nasdaq: GPRO) will lead another busy day of earnings reports on Wall Street. The firm will report earnings after the bell Thursday. Wall Street expects that the tech firm is about to report a loss of -$0.40 per share on top of $175.40 billion in revenue. Here’s a way to make a lot of money in a short time during earnings season. Spotify Technology SA(NYSE: SPOT) did not have a very good first earnings report. Shares plunged more than 8% after the firm’s music-streaming forecasts fell well short of expectations. During its earnings report, signals indicated that the firm’s growth could slow despite news that its

  • [By Paul Ausick]

    Pandora Media Inc. (NYSE: P) dropped about 2.2% Friday to post a new 52-week low of $4.39 after closing at $4.49 on Thursday. The stock’s 52-week high is $13.72. Volume was about 6.1 million, about 40% below the daily average of around 11 million. The music streaming company had no specific news.

  • [By Chris Lange]

    Pandora Media, Inc. (NYSE: P) released first quarter financial results after markets closed Thursday. The company reported a net loss of $0.27 per share on $319.2 million in revenue compared with consensus estimates from Thomson Reuters that called for a net loss of $0.38 per share on $304.3 million in revenue. The same period from last year had a net loss of $0.24 per share on $316 million in revenue.

Top 10 Value Stocks To Invest In Right Now: Discover Financial Services(DFS)

Advisors’ Opinion:

  • [By Max Byerly]

    DFSCoin (CURRENCY:DFS) traded flat against the dollar during the 1-day period ending at 18:00 PM E.T. on May 25th. One DFSCoin coin can currently be purchased for approximately $0.0722 or 0.00000810 BTC on popular exchanges. DFSCoin has a market cap of $1.28 million and $0.00 worth of DFSCoin was traded on exchanges in the last 24 hours. Over the last seven days, DFSCoin has traded down 3.6% against the dollar.

  • [By Shane Hupp]

    DFSCoin (CURRENCY:DFS) traded flat against the US dollar during the 24-hour period ending at 21:00 PM ET on June 8th. DFSCoin has a market capitalization of $1.28 million and approximately $0.00 worth of DFSCoin was traded on exchanges in the last 24 hours. During the last seven days, DFSCoin has traded down 3.6% against the US dollar. One DFSCoin coin can now be bought for about $0.0722 or 0.00000810 BTC on major cryptocurrency exchanges.

  • [By Matthew Cochrane]

    Over the past several quarters, Discover Financial Services (NYSE:DFS) has struggled to strike the proper balance between growing its loan portfolios and keeping its credit default risks in check. At least, that’s what Wall Street would have you believe. Discover’s management, however, maintains credit risk concerns are overblown. Meanwhile, the company continues to grow its loan portfolios at steady clips.

  • [By ]

    Selected examples: (BXP) , (DFS) , (HST) , (MA) , (TXN) , (USB) .

    Inflation Is a Key Risk

    Execs were most worried about inflation, as they should be.

  • [By Daniel B. Kline]

    On Tuesday, Discover Financial Services (NYSE:DFS) became the latest company to go all in on offering employees a way to get their degrees for free. Called “The Discover College Commitment,” the plan will cover tuition, fees, books, and even supplies for some online degrees at the University of Florida, Wilmington University, and Brandman University.

  • [By Matthew Cochrane]

    Both American Express Company (NYSE:AXP) and Discover Financial Services (NYSE:DFS) sport remarkably similar business models and, perhaps not coincidentally, have given investors almost identical returns over the past 12 months, both returning just over 22%. Which of these iconic companies makes for a better investment today?

Top 10 Value Stocks To Invest In Right Now: LGI Homes, Inc.(LGIH)

Advisors’ Opinion:

  • [By Logan Wallace]

    HL Financial Services LLC bought a new position in shares of LGI Homes (NASDAQ:LGIH) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,901 shares of the financial services provider’s stock, valued at approximately $769,000.

  • [By Tyler Crowe, Rich Smith, and Daniel Miller]

    So we asked three Motley Fool investors to highlight stocks they consider attractive stocks that might be a value investment today. Here’s why they picked General Motors (NYSE:GM),Loma Negra Compania Industrial Argentina(NYSE:LOMA), and LGI Homes (NASDAQ:LGIH).

  • [By Jason Hall]

    Priestley: LGI (NASDAQ:LGIH)is the last company we’re going to talk about. Again, they’reanother luxury home builderfocused in Delaware, Maryland, North Carolina, Pennsylvania and Virginia. Similarmarket cap to Meritage with $1.5 billion. The past 12 months,this stock is up 124%, which seems incredible.

Top 10 Value Stocks To Invest In Right Now: Magellan Midstream Partners L.P.(MMP)

Advisors’ Opinion:

  • [By ]

    That means pipelines are equally busy carrying all that raw crude into these refineries and then carrying out gasoline, diesel and other finished products. So you’d think these would be boon times for Magellan Midstream Partners (NYSE: MMP), which owns 10,000 miles of pipeline that connect with 50% of the nation’s refinery capacity.

  • [By ]

    Hetty Green Would Love This Trade
    It’s in Magellan Midstream Partners, L.P. (NYSE: MMP).

    Magellan Midstream Partners owns the longest refined petroleum products pipeline system in the country, with access to nearly 50% of the nation’s refining capacity and the ability to store more than 100 million barrels of petroleum products such as gasoline, diesel fuel and crude oil.

  • [By Lisa Levin] Gainers
    McDermott International, Inc. (NYSE: MDR) rose 19 percent to $7.20 in pre-market trading. Subsea 7 S.A. confirmed a $7.00 per share proposal to acquire McDermott.
    Clarus Corporation (NASDAQ: CLAR) rose 18.5 percent to $8.00 in pre-market trading.
    Enbridge Inc. (NYSE: ENB) rose 9.3 percent to $34.09 in pre-market trading after falling 2.41 percent on Friday.
    Lannett Company, Inc. (NYSE: LCI) rose 8.4 percent to $18 in pre-market trading. Lannett named Maureen M. Cavanaugh as senior vice president and chief commercial operations officer.
    Navios Maritime Midstream Partners L.P. (NYSE: NAP) rose 7.1 percent to $4.55 in pre-market trading after gaining 11.26 percent on Friday.
    Corcept Therapeutics Incorporated (NASDAQ: CORT) rose 6.9 percent to $18.80 in pre-market trading after falling 3.19 percent on Friday.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 5.7 percent to $2.40 in pre-market trading after falling 10.98 percent on Friday.
    Vectren Corporation (NYSE: VVC) shares rose 5.6 percent to $69.20 in pre-market trading. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash
    Genprex, Inc. (NASDAQ: GNPX) shares rose 5.2 percent to $4.50 in pre-market trading.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 5.1 percent to $3.70 in pre-market trading after declining 19.35 percent on Friday.
    Sangamo Therapeutics, Inc. (NASDAQ: SGMO) shares rose 5 percent to $20 in pre-market trading.
    Magellan Midstream Partners, L.P. (NYSE: MMP) shares rose 5 percent to $68.41 in pre-market trading.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares rose 4.9 percent to $19.78 in the pre-market trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Reuben Gregg Brewer]

    To put a number on its distribution growth, Phillips 66 Partners has increased its disbursement for 16 consecutive quarters (every quarter since its IPO) at a compound annual growth rate of 31%. That’s roughly the target it laid out for its first five years as a public entity. That is, of course, off of a low starting base. The year-over-year increase in the first-quarter distribution was around 20% — still a very impressive number when peers like Enterprise and Magellan Midstream Partners(NYSE:MMP) are offering up mid-to-high single-digit increases. (Kinder Morgan’s dividend growth will be huge in the coming years, but that’s a function of increasing the dividend after a painful cut.)

Top 10 Value Stocks To Invest In Right Now: Westport Innovations Inc(WPRT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook.
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings.
    Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings.
    Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter.
    Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116.
    Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings.
    The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million.
    Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701.
    Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO.
    Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales.
    Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
  • [By Maxx Chatsko]

    Shares of Westport Fuel Systems (NASDAQ:WPRT) jumped 11.9% last month, according to data provided by S&P Global Market Intelligence. But it wasn’t a smooth ride for shareholders.

  • [By Jason Hall]

    Furthermore, having a strong financial partner in Total to help it drive adoption of heavy-duty natural gas vehicles at this time could be a huge win. Prices of oil (and therefore diesel) have been steadily climbing over the past year, and the highly anticipated near-zero-emissions natural gas engine fromCummins(NYSE:CMI) andWestport Fuel Systems(NASDAQ:WPRT) is now being shipped to customers.

  • [By Joseph Griffin]

    Westport Fuel Systems Inc (NASDAQ:WPRT) (TSE:WPRT) has earned an average rating of “Buy” from the nine analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and six have issued a buy recommendation on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $3.86.

  • [By Daniel Miller]

    Shares of Westport Fuel Systems (NASDAQ:WPRT), a provider of high-performance, low-emission engine and fuel systems, are down 10% as of 11:20 a.m. EDT after the company reported its first-quarter results.

  • [By Dan Caplinger]

    Friday was a relatively quiet day on Wall Street, with a split among the most widely followed market benchmarks that sent some up and others down. Slight downticks in oil prices and bond yields marked minor reversals from upward trends earlier in the week, but investors are still watching both energy and bonds closely to see what long-term impact they might have on the stock market. Most attention centered on individual companies, some of which reported good news that sent their shares higher. Dell Technologies (NYSE:DVMT), Nektar Therapeutics (NASDAQ:NKTR), and Westport Fuel Systems (NASDAQ:WPRT) were among the best performers on the day. Here’s why they did so well.

Top 10 Value Stocks To Invest In Right Now: LightPath Technologies, Inc.(LPTH)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Joseph Griffin]

    Headlines about LightPath Technologies (NASDAQ:LPTH) have been trending somewhat positive on Monday, Accern Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. LightPath Technologies earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 46.9867601112654 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Hot Low Price Stocks For 2019

India’s gold demand grew by 9.1 per cent to 727 tonne in 2017 due to low prices coinciding with Dhanteras, positive economic backdrop and improved consumer sentiment especially in rural areas, according to a World Gold Council (WGC) report.

The total demand stood at 666.1 tonnes in 2016, WGC said in its latest Gold Demand Trends report.

“The demand was mainly driven by jewellery, which grew as GST stabilised, stock markets performed well and GDP growth leading to better economy and consumer sentiment, particularly in the rural areas, as the effect of demonetisation wore off,” WGC Managing Director, India, Somasundaram PR told PTI.

Also, the government’s decision to remove anti-money laundering regulation, the Prevention of Money Laundering Act (PMLA), from jewellery helped boost demand.

related news Waymo may try to push Uber ex-CEO’s buttons in car secrets trial 21.54 cr fake currency notes seized post demonetisation: Govt tells Lok Sabha No proposal to make Aadhaar mandatory for electoral bonds: Govt

The growth was mainly driven by jewellery demand in 2017, which was up by 12 per cent at 562.7 tonne compared to 504.5 tonne in 2016. In value terms jewellery demand was up 9 per cent at Rs 1,48,100 crore, from Rs 1,36,290 crore in 2016.

Hot Low Price Stocks For 2019: Long Island Iced Tea Corp. (LTEA)

Advisors’ Opinion:

  • [By ]

    5. Blockchain-Related Stocks
    Shorting blockchain-related stocks is an ideal way to not only short bitcoin but also short the entire cryptocurrency craze. Many such stocks exist, such as Riot Blockchain (Nasdaq: RIOT), Long Blockchain (Nasdaq: LTEA), and Longfin (Nasdaq: LFIN). Choose the one that you think is most overhyped and short away!

  • [By ]

    Long Island Ice Tea changed its name to Long Blockchain (Nasdaq: LTEA), sending shares 200% higher. It remains to be seen how a beverage maker will create shareholder value from blockchain technology — not that its investors care.

  • [By Garrett Baldwin]

    William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

Hot Low Price Stocks For 2019: First Community Corporation(FCCO)

Advisors’ Opinion:

  • [By Shane Hupp]

    First Community (NASDAQ:FCCO) issued its quarterly earnings data on Wednesday. The bank reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.04, Fidelity Earnings reports. The business had revenue of $11.17 million during the quarter, compared to the consensus estimate of $10.83 million. First Community had a net margin of 13.91% and a return on equity of 8.23%.

Hot Low Price Stocks For 2019: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Edited Transcript of MACK earnings conference call or presentation 8-May-18 12:30pm GMT (finance.yahoo.com) Investors Purchase High Volume of Merrimack Pharmaceuticals Call Options (MACK) (americanbankingnews.com) Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1 (finance.yahoo.com) Merrimack Pharmaceuticals (MACK) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS (americanbankingnews.com) Merrimack Pharmaceuticals’ (MACK) CEO Richard Peters on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com)

    A number of equities analysts have issued reports on MACK shares. Robert W. Baird reiterated a “hold” rating and issued a $12.00 price objective on shares of Merrimack Pharmaceuticals in a report on Thursday, March 15th. Zacks Investment Research upgraded Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective for the company in a report on Wednesday, April 25th.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

Hot Low Price Stocks For 2019: Xenia Hotels & Resorts, Inc.(XHR)

Advisors’ Opinion:

  • [By Shane Hupp]

    LSV Asset Management lifted its stake in Xenia Hotels & Resorts (NYSE:XHR) by 18.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,446,848 shares of the real estate investment trust’s stock after acquiring an additional 679,100 shares during the quarter. LSV Asset Management owned approximately 4.16% of Xenia Hotels & Resorts worth $87,691,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    MGM Resorts International (NYSE: MGM) and Xenia Hotels & Resorts (NYSE:XHR) are both consumer discretionary companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation.

  • [By Shane Hupp]

    Chicago Equity Partners LLC reduced its position in shares of Xenia Hotels & Resorts (NYSE:XHR) by 2.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 330,625 shares of the real estate investment trust’s stock after selling 9,325 shares during the quarter. Chicago Equity Partners LLC owned 0.31% of Xenia Hotels & Resorts worth $6,520,000 as of its most recent SEC filing.

Top 10 Bank Stocks To Own Right Now

This isn’t my first relationship with Royal Bancshares of Pennsylvania (NASDAQ:RBPAA). A decade or so ago, I bought shares in this regional bank when it paid a 4% dividend and churned out steady, if not spectacular earnings. For a number of years, I was content to toss my dividends back to Royal in return for more shares. My share count grew as did my comfort level with this cozy little investment. Well, the line between contentment and complacency is a fine one that’s easily crossed and once it is, things can become shall we say, interesting, if not downright dangerous. Without even realizing it, I had traversed that line and was about to pay the price.

I had warnings in 2006 and 2007 but if contentment is that warm glass of milk before bedtime, then complacency is a narcotic that no one, much less an investor, should ever ingest. By the time I finally came to my senses it was 2008, and we all know what happened in that wretched year; I sold my shares at a loss.

For the next couple of years, I busied myself with pursuits more rewarding than stock investing. You know, things like sorting my sock drawer, cleaning the garage, mowing the lawn and washing the car. As enthralling as these endeavors were, I couldn’t get Royal Bancshares out of my mind. The bank was like a favorite child to me; a child that had gone wrong. I decided to keep informed on this small regional bank to see where the drama might lead me. And this, dear reader, is where my sob story ends and the real story begins.

Top 10 Bank Stocks To Own Right Now: SPAR Group Inc.(SGRP)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested going long on small cap international merchandising and marketing services stockSPAR Group Inc (NASDAQ: SGRP):

Top 10 Bank Stocks To Own Right Now: Investment Technology Group, Inc.(ITG)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Investment Technology Group Inc. (NYSE: ITG) was downgraded to Market Perform from outperform by KeefeBruyette & Woods.

    Liquidity Services Inc. (NASDAQ: LQDT) was raised to Buy from Underperform, and the price target was raised up to $45 from $28.50, at Merrill Lynch.

Top 10 Bank Stocks To Own Right Now: Pilbara Minerals Limited (PILBF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

Top 10 Bank Stocks To Own Right Now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

Top 10 Bank Stocks To Own Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday. Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter. Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday. Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday. Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances. Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral. Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday. Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems. Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend. BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc. Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday. Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Benzinga News Desk]

    On Wednesday, just 24 hours after Amazon announced its first major sports deal — tying up with the NFL to stream 10 Thursday night games — Alphabet Inc (NASDAQ: GOOGL) laid claim to viewers’ credit cards by debuting YouTube TV, a bundle of 50 major television channels for $35 per month: Link

    ECONOMIC DATA March 2017 US Challenger layoffs report 43,310 vs 36,975 Initial Jobless Claims for Mar 31 234.0K vs 250.0K estimate; Continuing Claims for Mar 24 2.03M vs 2.04M estimate. San Francisco Federal Reserve Bank President John Williams is set to speak in Frankfurt at 9:30 a.m. ET. The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET. Data on money supply for the recent week will be released at 4:30 p.m. ET. ANALYST RATINGS Goldman Sachs initiated Advanced Micro Devices (NASDAQ: AMD) at Sell JMP Securities upgraded NetApp (NASDAQ: NTAP) from Market Underperform to Market Perform PiperJaffray upgraded Abiomed (NASDAQ: ABMD) from Neutral to Overweight Deutsche Bank downgraded T-Mobile (NASDAQ: TMUS) from Buy to Hold Mizuho downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Buy to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

Top 10 Bank Stocks To Own Right Now: Mead Johnson Nutrition Company(MJN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The group agreed to sell its food business to McCormick & Company Inc. (MKC)  last week for $4.2 billion. Reckitt said it would use the sale proceeds to reduce debt, which grew by $21 billion through a pair of financing transactions in March led by Bank of America Merrill Lynch, Deutsche Bank and HSBC in order to fund its $18 billion acquisition of infant nutrition group Mead Johnson (MJN) earlier this year.

  • [By Michael Flannelly]

    On Tuesday, JP Morgan analysts upgraded children’s nutrition company Mead Johnson Nutrition (MJN), as they believe the company’s top line growth should be valued more highly than the possible cost headwinds and further Chinese regulations.

    The analysts upgraded MJN from “Neutral” to “Overweight” and see shares reaching $88. This price target suggests a 16% upside to the stock’s Monday closing price of $76.11.

    Mead Johnson Nutrition shares were up 85 cents, or 1.12%, during morning trading on Tuesday. The stock is up 16.71% year-to-date.

Top 10 Bank Stocks To Own Right Now: U S Concrete, Inc.(USCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, basic materials shares fell 0.73 percent. Meanwhile, top losers in the sector included US Concrete Inc (NASDAQ: USCR), down 8 percent, and Seabridge Gold, Inc. (USA) (NYSE: SA), down 5 percent.

  • [By WWW.THESTREET.COM]

    Coming up in tonight’s episode of Mad Money: Cramer interviews Bill Sandbrook, CEO of U.S. Concrete (USCR)  and focuses on opportunities for Xilinx (XLNX) .  Plus, don’t miss the Lightning Round. Which stocks is Cramer bullish on?

  • [By Lisa Levin]

    In trading on Friday, basic materials shares fell 0.36 percent. Meanwhile, top losers in the sector included US Concrete Inc (NASDAQ: USCR), down 10 percent, and Commercial Metals Company (NYSE: CMC), down 4 percent.

Top 10 Bank Stocks To Own Right Now: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Yet some solid individual stock gains also helped lift investors’ moods, and Sears Holdings (NASDAQ:SHLD), National Beverage (NASDAQ:FIZZ), and JetBlue Airways (NASDAQ:JBLU) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Demitrios Kalogeropoulos]

    Tailored Brands (NYSE:TLRD) and National Beverage (NASDAQ:FIZZ) were two of the biggest individual stock movers on Thursday.

    Winners and losers

    Shares of formal clothing specialist Tailored Brands dove 32% after the companyposted surprisingly weak fiscal fourth-quarter earnings results. Sales fell 3.9% to $793 million, while consensus estimates were targeting a more modest decline to $805 million.

Top 10 Bank Stocks To Own Right Now: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Paul Ausick]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped nearly 11% on Tuesday to post a new 52-week low of $3.30 after closing at $3.67 on Monday. Volume was more than 3 times the daily average of about 3.7 million shares. The stock’s 52-week high is $9.02 The company said Tuesday that it has sold some of its cancer drugs to Ipsen for $1 billion.

  • [By Lisa Levin] Gainers Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday. Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter. Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday. Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday. Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances. Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral. Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday. Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems. Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend. BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc. Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday. Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Paul Ausick]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped 9% on Thursday to post a new 52-week low of $3.72 after closing at $4.09 on Wednesday. Volume was more than double the daily average of about 3 million shares. The company had no specific news Thursday.

  • [By Peter Graham]

    Small cap cancer stock Merrimack Pharmaceuticals Inc (NASDAQ: MACK) reported Q1 2017 earnings before the market opened this morning. In early January, Merrimack Pharmaceuticals had announced a definitive asset purchase and sale agreement with Ipsen SA (EPA: IPN; IPSEY) for a transaction valued at up to $1.025 billion (plus up to $33 million in net milestone payments retained by Merrimack pursuant to Merrimack’s exclusive licensing agreement with Shire) under which Merrimack would:

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap cancer stock Merrimack Pharmaceuticals Inc (NASDAQ: MACK) is scheduled for before the market opens on Wednesday (March 1st). In early January, Merrimack Pharmaceuticals reportedadefinitive asset purchase and sale agreement with Ipsen SA (EPA: IPN; IPSEY) for a transaction valued at up to $1.025 billion (plus up to $33 million in net milestone payments retained by Merrimack pursuant to Merrimack’s exclusive licensing agreement with Shire) under which Merrimack will:

Top 10 Bank Stocks To Own Right Now: Gold Standard Ventures Corporation(GSV)

Advisors’ Opinion:

  • [By Sara Cornell]

    The management team member who garners the most attention right now is Dave Mathewson, VP, Head of Exploration. Dave is a geologist with more than 35 years’ experience in the gold exploration space, and specifically, in Nevada. He is credited with a number of notable discoveries for Newmont Mining Corp (NYSE: NEM), and later went on to Gold Standard Ventures Corp (NYSE: GSV) helping take that company from a start-up to a now $481 million market cap.

Top Financial Stocks To Buy For 2017

European stocks slipped Tuesday, dampened by downbeat data from Germany, the continents largest economy, before the European Central Bank issues a policy update later this week.

The Stoxx Europe 600 SXXP, -0.14% was off by 0.1% at 373.01, led by utility, health care and financial shares. But gains for consumer goods, basic materials and technology stocks helped cap the overall decline.

Top Financial Stocks To Buy For 2017: The Bon-Ton Stores, Inc.(BONT)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q3 2016 earnings report for small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)is scheduled for before the market opens on Thursday (November 17th) as traditional department stores continue to struggle to figure out how to attract costumers into their stores as online giants increasingly become thedominant retail players.

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)is scheduled for before the market opens on Tuesday (March 14th). In January, The Bon-Ton Stores announced that its comparable store sales for the nine-week holiday period ended December 31, 2016 had decreased 3.1% -in line with guidance. The CEO commented:

Top Financial Stocks To Buy For 2017: Williams Partners L.P.(WPZ)

Advisors’ Opinion:

  • [By Ben Levisohn]

    In a release after the close on Monday, Williams and Williams Partners (WPZ) made several announcements, including: 1) outlining managements plan to financially reposition and simplify the franchises GP/LP structure in an ~$11.4 billion transaction (not subject to any additional approvals), 2) adjustments to Williams and Williams Partners’ dividend and distribution payouts, 3) initiating a ~$2+ billion William equity raise to fund a further Williams investment in Williams Partners, 4) noted other potential upcoming changes, including the sale of ~$2 billion in non-core assets in 2017, and 5) provided several forms of updated 2017 guidance…

Top Financial Stocks To Buy For 2017: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Paul Ausick]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped 9% on Thursday to post a new 52-week low of $3.72 after closing at $4.09 on Wednesday. Volume was more than double the daily average of about 3 million shares. The company had no specific news Thursday.

  • [By Peter Graham]

    Small cap cancer stock Merrimack Pharmaceuticals Inc (NASDAQ: MACK) reported Q1 2017 earnings before the market opened this morning. In early January, Merrimack Pharmaceuticals had announced a definitive asset purchase and sale agreement with Ipsen SA (EPA: IPN; IPSEY) for a transaction valued at up to $1.025 billion (plus up to $33 million in net milestone payments retained by Merrimack pursuant to Merrimack’s exclusive licensing agreement with Shire) under which Merrimack would:

  • [By Lisa Levin] Gainers Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday. Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter. Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday. Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday. Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances. Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral. Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday. Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems. Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend. BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc. Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday. Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than